[go: up one dir, main page]

HK1088336A1 - Process for the preparation of anticonvulsant derivatives of topiramate - Google Patents

Process for the preparation of anticonvulsant derivatives of topiramate

Info

Publication number
HK1088336A1
HK1088336A1 HK06108677A HK06108677A HK1088336A1 HK 1088336 A1 HK1088336 A1 HK 1088336A1 HK 06108677 A HK06108677 A HK 06108677A HK 06108677 A HK06108677 A HK 06108677A HK 1088336 A1 HK1088336 A1 HK 1088336A1
Authority
HK
Hong Kong
Prior art keywords
topiramate
preparation
anticonvulsant derivatives
anticonvulsant
derivatives
Prior art date
Application number
HK06108677A
Other languages
English (en)
Inventor
Berkner Joachim Ernst
Duncan Scott
Mills John
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HK1088336A1 publication Critical patent/HK1088336A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
HK06108677A 2003-03-04 2006-08-04 Process for the preparation of anticonvulsant derivatives of topiramate HK1088336A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45186303P 2003-03-04 2003-03-04
PCT/US2004/006263 WO2004078769A1 (en) 2003-03-04 2004-03-02 Process for the preparation of anticonvulsant derivatives of topiramate

Publications (1)

Publication Number Publication Date
HK1088336A1 true HK1088336A1 (en) 2006-11-03

Family

ID=32962650

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06108677A HK1088336A1 (en) 2003-03-04 2006-08-04 Process for the preparation of anticonvulsant derivatives of topiramate

Country Status (27)

Country Link
US (1) US7157589B2 (pt)
EP (1) EP1599490B8 (pt)
JP (1) JP4725976B2 (pt)
KR (1) KR20050119111A (pt)
CN (1) CN100376591C (pt)
AR (1) AR043466A1 (pt)
AT (1) ATE421521T1 (pt)
AU (1) AU2004217974A1 (pt)
BR (1) BRPI0407967A (pt)
CA (1) CA2517964A1 (pt)
CL (1) CL2004000438A1 (pt)
DE (1) DE602004019191D1 (pt)
DK (1) DK1599490T3 (pt)
ES (1) ES2254047T3 (pt)
HK (1) HK1088336A1 (pt)
HR (1) HRP20050756A2 (pt)
MX (1) MXPA05009384A (pt)
MY (1) MY139235A (pt)
NO (1) NO20054538L (pt)
NZ (1) NZ541811A (pt)
PT (1) PT1599490E (pt)
RU (1) RU2333216C2 (pt)
SI (1) SI1599490T1 (pt)
TW (1) TW200504089A (pt)
UA (1) UA81657C2 (pt)
WO (1) WO2004078769A1 (pt)
ZA (1) ZA200507995B (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
WO2007099388A1 (en) * 2006-03-01 2007-09-07 Glade Organics Private Limited An improved process for the manufacture of topiramate
WO2008010231A2 (en) * 2006-05-26 2008-01-24 Alembic Limited A process for the purification of topiramate
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US9303038B2 (en) 2011-09-06 2016-04-05 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological diseases
CA2872975A1 (en) 2012-05-07 2013-11-14 Cellixbio Private Limited Compositions and methods for the treatment of neurological disorders
CN104603096A (zh) 2012-05-07 2015-05-06 塞利克斯比奥私人有限公司 用于治疗神经肌肉障碍和神经退行性疾病的组合物和方法
US9399634B2 (en) 2012-05-07 2016-07-26 Cellix Bio Private Limited Compositions and methods for the treatment of depression
US9266823B2 (en) 2012-05-08 2016-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of parkinson's disease
US9434704B2 (en) 2012-05-08 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of neurological degenerative disorders
WO2013167991A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic disorders
WO2013167992A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of inflammatory disorders
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
WO2013168000A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of severe pain
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
WO2013168011A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of chronic pain
WO2013168001A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
US9499526B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
WO2013168015A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of asthma and allergy
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
SG11201407318UA (en) 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of metabolic syndrome
US9499527B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013168012A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
US9315478B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
WO2013168005A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
CN104603100A (zh) 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
WO2013175344A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
EP2852571A4 (en) 2012-05-23 2015-11-25 Cellix Bio Private Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF MUCOSITIS
US9227974B2 (en) 2012-05-23 2016-01-05 Cellex Bio Private Limited Compositions and methods for the treatment of respiratory disorders
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en) 2012-08-03 2014-02-06 Mahesh Kandula Compositions and methods for the treatment migraine and neurologic diseases
WO2014037833A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment inflammation and lipid disorders
CA2873029A1 (en) 2012-09-08 2014-03-13 Cellixbio Private Limited Compositions and methods for the treatment of inflammation and lipid disorders
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
EP3004049B1 (en) 2013-06-04 2018-09-05 Cellixbio Private Limited Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
CA2976314C (en) 2014-09-26 2021-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
SG11201702554QA (en) 2014-09-29 2017-04-27 Cellix Bio Private Ltd Compositions and methods for the treatment of multiple sclerosis
CA2965449C (en) 2014-10-27 2020-11-10 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
CN107428697A (zh) 2015-01-06 2017-12-01 塞尔利克斯生物私人有限公司 用于治疗炎症和疼痛的组合物和方法
CN106632530A (zh) * 2016-12-08 2017-05-10 陕西大生制药科技有限公司 高纯度托吡酯的制备方法
CN108341844A (zh) * 2018-04-25 2018-07-31 广州小桔生物科技有限公司 一种高纯度托吡酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol

Also Published As

Publication number Publication date
AR043466A1 (es) 2005-07-27
US20040215004A1 (en) 2004-10-28
ES2254047T1 (es) 2006-06-16
EP1599490B8 (en) 2009-04-08
ZA200507995B (en) 2007-01-31
NO20054538L (no) 2005-10-03
MY139235A (en) 2009-09-30
CN100376591C (zh) 2008-03-26
EP1599490A1 (en) 2005-11-30
SI1599490T1 (sl) 2009-06-30
JP4725976B2 (ja) 2011-07-13
UA81657C2 (ru) 2008-01-25
DK1599490T3 (da) 2009-04-27
EP1599490B1 (en) 2009-01-21
HRP20050756A2 (en) 2006-07-31
JP2006519860A (ja) 2006-08-31
CA2517964A1 (en) 2004-09-16
PT1599490E (pt) 2009-04-03
CL2004000438A1 (es) 2005-01-21
ATE421521T1 (de) 2009-02-15
WO2004078769A1 (en) 2004-09-16
CN1756760A (zh) 2006-04-05
RU2005127626A (ru) 2006-01-27
AU2004217974A1 (en) 2004-09-16
MXPA05009384A (es) 2006-02-28
TW200504089A (en) 2005-02-01
DE602004019191D1 (de) 2009-03-12
US7157589B2 (en) 2007-01-02
NZ541811A (en) 2008-07-31
RU2333216C2 (ru) 2008-09-10
KR20050119111A (ko) 2005-12-20
BRPI0407967A (pt) 2006-03-07
ES2254047T3 (es) 2009-05-14

Similar Documents

Publication Publication Date Title
HK1088336A1 (en) Process for the preparation of anticonvulsant derivatives of topiramate
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL216449A0 (en) Process for the preparation of tetrazole derivatives
TWI365887B (en) Process for the preparation of polycarbonates
HK1085480A1 (en) Process for the preparation of roflumilast
HRP20150163T1 (en) Process for the preparation of n-substituted 2-cyanopyrrolidines
IL176472A0 (en) Process for the preparation of pyridine derivatives
ZA200507297B (en) Process for preparation of phenethylamine derivatives
IL175138A (en) Process for the preparation of (s)- or (r)- 4 - halo-3- hydroxybutyrates
IL175743A0 (en) Process for the preparation of thiazolopyrimidines
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
HUP0303443A3 (en) Process for the preparation of imidazole derivatives
EG23973A (en) Process for the preparation of urea ganules
IL175156A0 (en) Process for the preparation of gabapentin
IL162385A0 (en) Process for the preparation of echinocandin derivatives
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
EP1646640A4 (en) PROCESS FOR PREPARING HIGH-PURITY 1-ANDROSTEN DERIVATIVES
IL171789A (en) Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
HK1087111A1 (en) Process for the preparation of nicotinaldehydes
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL376538A1 (pl) Ciągły sposób wytwarzania pochodnych sulfiamianu fruktopiranozy
ZA200603113B (en) Process for the preparation of risperidone

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220302